Page 138 - 《中国药房》2025年2期

[20] NIESKENS T T G，SJÖGREN A K. Emerging in vitro sys‐ rescence based probe for precision diagnosis of kidney in‐
tems to screen and predict drug-induced kidney toxicity jury[J]. Chem Commun（Camb），2019，55（13）：1955-
[J]. Semin Nephrol，2019，39（2）：215-226. 1958.
[21] LIU L Q，LIU Y X，XIN Y，et al. An early and stable [33] ETHERINGTON C，BOSOMWORTH M，CLIFTON I，et
mouse model of polymyxin-induced acute kidney injury al. Measurement of urinary N-acetyl-β-D-glucosaminidase
[J]. Intensive Care Med Exp，2024，12（1）：88. in adult patients with cystic fibrosis：before，during and
[22] BABIC J T，MANCHANDANI P，LEDESMA K R，et al. after treatment with intravenous antibiotics[J]. J Cyst
Evaluation of urinary KIM-1 for prediction of polymyxin Fibros，2007，6（1）：67-73.
B-induced nephrotoxicity[J]. Antimicrob Agents Che‐ [34] SUZUKI T，YAMAGUCHI H，OGURA J，et al. Megalin
mother，2017，61（11）：e01735-17. contributes to kidney accumulation and nephrotoxicity of
[23] KIM K，LEE A，RYU J Y，et al. Application of microflui- colistin[J]. Antimicrob Agents Chemother，2013，57（12）：
dic perfusion culture for assessment of colistin nephroto- 6319-6324.
xicity[J]. Rom Biotechnol Lett，2020，25（4）：1724-1730. [35] 张潇伊，蒯铮，邹云增. β2-微球蛋白的研究进展[J]. 中国
[24] ROMEJKO K，MARKOWSKA M，NIEMCZYK S. The 临床药理学与治疗学，2022，27（4）：390-396.
review of current knowledge on neutrophil gelatinase- ZHANG X Y，KUAI Z，ZOU Y Z. Research progress of
associated lipocalin（NGAL）[J]. Int J Mol Sci，2023，24 β2 microglobulin[J]. Chin J Clin Pharmacol Ther，2022，
（13）：10470. 27（4）：390-396.
[25] SISTI G，RUBIN G，ZHOU C，et al. Neutrophil [36] LIU Z Y，TANG F，WANG J，et al. Serum beta2-micro‐
gelatinase-associated lipocalin as a predictor of pre- globulin acts as a biomarker for severity and prognosis in
eclampsia：a systematic review and meta-analysis[J]. Int J glioma patients：a preliminary clinical study[J]. BMC Can‐
Gynaecol Obstet，2023，163（1）：63-74. cer，2024，24（1）：692.
[26] DA Y，AKALYA K，MURALI T，et al. Serial quantifica‐ [37] LOCCI E，LIU J J，PAIS G M，et al. Urinary metabolo‐
tion of urinary protein biomarkers to predict drug-induced mics from a dose-fractionated polymyxin B rat model of
acute kidney injury[J]. Curr Drug Metab，2019，20（8）： acute kidney injury[J]. Int J Antimicrob Agents，2022，60
656-664. （1）：106593.
[27] ORDOOEI JAVAN A，SALAMZADEH J，SHOKOUHI [38] KEIRSTEAD N D，WAGONER M P，BENTLEY P，et al.
S，et al. Evaluation of renal toxicity of colistin therapy Early prediction of polymyxin-induced nephrotoxicity
with neutrophil gelatinase-associated lipocalin：a bio‐ with next-generation urinary kidney injury biomarkers[J].
marker of renal tubular damage[J]. Iran J Kidney Dis， Toxicol Sci，2014，137（2）：278-291.
2017，11（6）：447-455. [39] HART A，CESAR F，ZELNICK L R，et al. Identification
[28] SHAVIT L，MANILOV R，WIENER-WELL Y，et al. Uri‐ of prognostic biomarkers for antibiotic associated nephro‐
nary neutrophil gelatinase-associated lipocalin for early toxicity in cystic fibrosis[J]. J Cyst Fibros，2024，23（2）：
detection of acute kidney injury in geriatric patients with 293-299.
urinary tract infection treated by colistin[J]. Clin Nephrol， [40] ZHOU Z Z，ZHANG D L，WANG Y J，et al. Urinary exo‐
2013，80（6）：405-416. somes：a promising biomarker of drug-induced nephroto-
[29] LATOCH E， KONOŃCZUK K， MUSZYŃSKA- xicity[J]. Front Med，2023，10：1251839.
ROSŁAN K，et al. Urine NGAL and KIM-1-tubular injury [41] BAZARGANI B，MOGHTADERI M. New biomarkers in
biomarkers in long-term survivors of childhood solid tu‐ early diagnosis of acute kidney injury in children[J]. Avi‐
mors：a cross-sectional study[J]. J Clin Med，2021，10 cenna J Med Biotechnol，2022，14（4）：264-269.
（3）：399. [42] KAMIANOWSKA M， RYBI-SZUMIŃSKA A，
[30] PETROVA I，ALEXANDROV A，VLADIMIROV G，et KAMIANOWSKA A，et al. Urinary concentration of renal
al. NGAL as biomarker of clinical and subclinical damage biomarkers in healthy term neonates：gender differences in
of kidney function after coronary angiography[J]. Diag‐ GST-pi excretion[J]. Med Sci Monit，2024，30：e942819.
nostics，2023，13（6）：1180. [43] KATOU，GLOBKE B，MORGUL M H，et al. Urinary bio‐
[31] KIM H K，LEE M，LEE Y H，et al. Renal tubular damage markers α-GST and π-GST for evaluation and monitoring
marker，urinary N-acetyl-β-D-glucosaminidase，as a pre‐ in living and deceased donor kidney grafts[J]. J Clin Med，
dictive marker of hepatic fibrosis in type 2 diabetes mel- 2019，8（11）：1899.
litus[J]. Diabetes Metab J，2022，46（1）：104-116. （收稿日期：2024-07-30 修回日期：2024-12-26）
[32] YAN F，TIAN X G，LUAN Z L，et al. NAG-targeting fluo‐ （编辑：孙 冰）

· 256 · China Pharmacy 2025 Vol. 36 No. 2 中国药房 2025年第36卷第2期